Table 3 Associated chemotherapy and regimens
From: Pattern of use of radiotherapy for lung cancer: a descriptive study
Associated chemotherapy | Regimen | ||||
|---|---|---|---|---|---|
Patients (%) | Patients (%) | ||||
NSCLC | SCLC | NSCLC | SCLC | ||
No | 163 (33) | 16 (14) | CDDP + Taxol | 15 (3) | - |
Sequential | 153 (31) | 35 (30) | Carbo + Taxol | 153 (31) | - |
Concomitant | 153 (31) | 59 (51) | CDDP + GMZ | 84 (17) | 2 (2) |
Both | 25 (5) | 6 (5) | CDDP + VNB | 84 (17) | 2 (2) |
Total | 494 (100) | 116 (100) | CDDP + VP-16 | 15 (3) | 53 (46) |
Carbo + VP-16 | 15 (3) | 52 (45) | |||
Other | 128 (26) | 7 (5) | |||
Total | 494 (100) | 116 (100) | |||